JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5101
Taylor Devices
TAYD
$177M
| $292K | ﹤0.01% |
7,010
+5,976
| +578% | +$272K |
2024 Q2
2 quarters
|
|
5102
PUT
Cytokinetics
CYTK
$9.12B
| $292K | ﹤0.01% |
6,200
-36,200
| -85% | -$1.88M |
2023 Q4
4 quarters
|
|
5103
OptimizeRx
OPRX
$161M
| $291K | ﹤0.01% |
59,952
+52,169
| +670% | +$292K |
2018 Q4
24 quarters
|
|
5104
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.59B
| $290K | ﹤0.01% |
2,978
-2,250
| -43% | -$211K |
2022 Q4
8 quarters
|
|
5105
PUT
Nice
NICE
$6.67B
| $289K | ﹤0.01% |
1,700
-200
| -11% | -$35.7K |
2023 Q4
4 quarters
|
|
|
PLL
5106
DELISTED
Piedmont Lithium
PLL
| $288K | ﹤0.01% |
32,938
+1,878
| +6% | +$22K |
2021 Q2
14 quarters
|
|
5107
Black Stone Minerals
BSM
$3.1B
| $288K | ﹤0.01% |
19,714
+14,714
| +294% | +$219K |
2024 Q3
1 quarter
|
|
5108
Innovator US Equity Power Buffer ETF March
PMAR
$748M
| $288K | ﹤0.01% |
7,159
+2,986
| +72% | +$119K |
2024 Q2
2 quarters
|
|
|
TERN
5109
DELISTED
Terns Pharmaceuticals
TERN
| $287K | ﹤0.01% |
51,830
-7,706
| -13% | -$52.2K |
2021 Q1
15 quarters
|
|
|
ACCD
5110
DELISTED
Accolade Inc
ACCD
| $285K | ﹤0.01% |
83,257
+28,238
| +51% | +$100K |
2020 Q3
17 quarters
|
|
5111
Alvotech
ALVO
$1.94B
| $285K | ﹤0.01% |
21,508
+19,799
| +1,159% | +$244K |
2024 Q1
3 quarters
|
|
5112
Principal Spectrum Preferred Securities Active ETF
PREF
$1.85B
| $284K | ﹤0.01% |
15,271
-25,632
| -63% | -$480K |
2024 Q2
2 quarters
|
|
|
KC
5113
Kingsoft Cloud Holdings
KC
$2.69B
| $284K | ﹤0.01% |
27,081
-73,528
| -73% | -$419K |
2023 Q1
7 quarters
|
|
5114
Nuveen ESG Large-Cap Growth ETF
NULG
$3.07B
| $284K | ﹤0.01% |
3,309
+1,628
| +97% | +$141K |
2021 Q4
12 quarters
|
|
5115
Atlanticus Holdings
ATLC
$1.39B
| $283K | ﹤0.01% |
5,079
+180
| +4% | +$8.55K |
2020 Q2
18 quarters
|
|
|
LAZR
5116
PUT
DELISTED
Luminar Technologies
LAZR
| $283K | ﹤0.01% |
52,644
-5,849
| -10% | -$61.8K |
2024 Q3
1 quarter
|
|
5117
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.4B
| $283K | ﹤0.01% |
11,162
-159
| -1% | -$4.14K |
2021 Q2
14 quarters
|
|
|
5118
CALL
Cytokinetics
CYTK
$9.12B
| $282K | ﹤0.01% |
6,000
-30,000
| -83% | -$1.56M |
2023 Q4
4 quarters
|
|
5119
Hagerty
HGTY
$1.52B
| $281K | ﹤0.01% |
29,139
+27,864
| +2,185% | +$303K |
2024 Q3
1 quarter
|
|
5120
ThredUp
TDUP
$285M
| $280K | ﹤0.01% |
201,755
+165,115
| +451% | +$185K |
2021 Q1
15 quarters
|
|
5121
Cerus
CERS
$459M
| $280K | ﹤0.01% |
181,913
+101,550
| +126% | +$175K |
2017 Q1
31 quarters
|
|
5122
iShares Bitcoin Trust
IBIT
$67.2B
| $278K | ﹤0.01% |
5,242
+4,855
| +1,255% | +$229K |
2024 Q3
1 quarter
|
|
5123
PUT
Madrigal Pharmaceuticals
MDGL
$11.5B
| $278K | ﹤0.01% |
900
-15,000
| -94% | -$4.22M |
2024 Q1
3 quarters
|
|
5124
Lyell Immunopharma
LYEL
$227M
| $277K | ﹤0.01% |
21,663
+16,826
| +348% | +$334K |
2021 Q3
13 quarters
|
|
|
GES
5125
DELISTED
Guess Inc
GES
| $276K | ﹤0.01% |
19,602
-72,879
| -79% | -$1.24M |
2013 Q2
46 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.